Viewing StudyNCT00466960



Ignite Creation Date: 2024-05-05 @ 5:29 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00466960
Status: COMPLETED
Last Update Posted: 2017-08-28
First Post: 2007-04-25

Brief Title: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
Sponsor: University of Washington
Organization: University of Washington

Organization Data

Organization: University of Washington
Class: OTHER
Study ID: 6168
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Washington
Lead Sponsor Class: OTHER
Responsible Party: Barbara Goff
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: University of Washington
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH